Compare Nexgen Energy Ltd. Common Shares (NXE) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nexgen Energy Ltd. Common Shares vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nexgen Energy Ltd. Common Shares trades at $8.82 (market cap $5.80B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.68 (market cap $2.27B). The key difference: Nexgen Energy Ltd. Common Shares is far larger — about 2.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Nexgen Energy Ltd. Common Shares nearer its low. Which is the better fit depends on your goals.
| NXE | SLS | |
|---|---|---|
Market Cap | $5.80B | $2.27B |
Volume | 6,795,738 | 4,179,659 |
Sector | Energy | Health |
52-Week High | $13.92 | $15.46 |
52-Week Low | $7.56 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $5.55B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nexgen Energy Ltd. Common Shares
NexGen Energy develops uranium projects in Canada. Its main asset is the Rook I Project in Saskatchewan, which includes the Arrow uranium deposit.
Read more on NXE →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
